| MeSH term | MeSH ID | Detail |
|---|---|---|
| Erectile Dysfunction | D007172 | 19 associated lipids |
| Infarction, Middle Cerebral Artery | D020244 | 35 associated lipids |
| Stroke | D020521 | 32 associated lipids |
| Liver Cirrhosis, Biliary | D008105 | 12 associated lipids |
| Hyperlipoproteinemia Type II | D006938 | 22 associated lipids |
| Hyperlipoproteinemia Type IV | D006953 | 6 associated lipids |
| Nephrotic Syndrome | D009404 | 11 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Leukemia, Myeloid | D007951 | 52 associated lipids |
| Respiratory Distress Syndrome, Adult | D012128 | 15 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zhou Z et al. | Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: Role of thromboxane and purinergic receptors. | 2015 | Vascul. Pharmacol. | pmid:25921923 |
| Larsen SB et al. | Calprotectin and platelet aggregation in patients with stable coronary artery disease. | 2015 | PLoS ONE | pmid:25970343 |
| Lourenço AL et al. | Synthesis and antiplatelet activity of antithrombotic thiourea compounds: biological and structure-activity relationship studies. | 2015 | Molecules | pmid:25903367 |
| Sahota T et al. | Model-based prediction of the acute and long-term safety profile of naproxen in rats. | 2015 | Br. J. Pharmacol. | pmid:25884765 |
| Violi F et al. | Reply: platelet activation and pneumonia: is soluble p-selectin the right marker? | 2015 | J. Am. Coll. Cardiol. | pmid:25857924 |
| Gurbel PA et al. | Platelet activation and pneumonia: is soluble p-selectin the right marker? | 2015 | J. Am. Coll. Cardiol. | pmid:25857923 |
| Violi F et al. | Reply: myocardial infarction in patients with pneumonia. | 2015 | J. Am. Coll. Cardiol. | pmid:25857922 |
| Karamouzis I et al. | Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome. | 2015 | Clin. Endocrinol. (Oxf) | pmid:24923553 |
| Willenberg I et al. | Determining cyclooxygenase-2 activity in three different test systems utilizing online-solid phase extraction-liquid chromatography-mass spectrometry for parallel quantification of prostaglandin E(2), D(2) and thromboxane B(2). | 2015 | J Chromatogr A | pmid:25777050 |
| Wang J et al. | Prevention of atherosclerosis by Yindan Xinnaotong capsule combined with swimming in rats. | 2015 | BMC Complement Altern Med | pmid:25886942 |